Nutranomics, Inc. engages in the research, development, and sale of nutritional food products. It offers approximately 480 nutritional supplements, including formulating vitamin, mineral, herbal, and probiotic supplements. The company provides Nutritional Blood Analysis, a tool to examine the customer's blood cells on a video monitor, live, in real time; and the patented Assimilation Enhancing Sys...
Nutranomics reported revenue of $1.79 million for fiscal year 2015, down 25.5% from fiscal year 2014, and net income of -$1.22 million. In Q1 2016 (the quarter ended October 31, 2015) revenue was $409,216, down 36.2% from a year before. Its largest business segment, Product Sales, brought in 100% of segment revenue in fiscal year 2014; Americas was the largest region with 66%. Its market capitalization was $816,232 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended July 31, 2015; market data as of October 8, 2026.
No profile data available.